STOCKHOLDERS' EQUITY (Details Narrative) - USD ($)			1 Months Ended		3 Months Ended			5 Months Ended	9 Months Ended
	Nov. 06, 2017	Oct. 05, 2017	Dec. 20, 2018	Dec. 18, 2018	Dec. 31, 2019	Jun. 30, 2019	Dec. 31, 2018	Mar. 31, 2019	Dec. 31, 2019	Dec. 31, 2018	Mar. 31, 2018
Reverse stock split									one (1) for ten (10) basis
Conversion of common stock		13,732,400
Common stock converted into convertible Preferred Stock		13,732
Conversion basis		Each share of Series A Preferred into 100 shares of common stock of the Company
Cancellation of common stock	13,732,400
Common Stock, Shares Issued					20,808,348			20,765,592	20,808,348		6,767,600
Common Stock, Shares Outstanding					20,808,348			20,765,592	20,808,348		6,767,600
Sale of remaining common stock					19,392,402				19,392,402
Common stock, par value					$ 0.001			$ 0.001	$ 0.001
Proceeds from warrants									$ 89,811
Proceeds from sale of common stock and warrants									$ 0	$ 2,019,743
Warrants exercised									8,636
Distribution Agreement
Number of common stock sold						14,339		23,500
Proceeds from common stock sold						$ 152,492		$ 455,105
Related cost						$ 9,575		$ 161,103
Placement agency agreement
Number of common stock sold			194,206	240,000
Public offering price				$ 10.4
Common stock, par value				0.001
Sale of warrants			194,206
Proceeds from warrants			$ 2,019,743
Proceeds from sale of common stock and warrants			1,691,498
Placement agent commissions			$ 328,245
Warrants exercisable				$ 13.0
Warrants term				3 years
Share capital
Anti-dilutive common stock					1,000,000		1,000,000		1,000,000	1,000,000
Warrants [Member]
Anti-dilutive common stock					185,570				185,570
Warrants One [Member]
Anti-dilutive common stock					9,710				9,710
Warrants One [Member] | Placement agency agreement
Anti-dilutive common stock				9,710
Option [Member]
Anti-dilutive common stock					9,710				9,710
Option [Member] | Placement agency agreement
Anti-dilutive common stock				9,710